Jean T. Barbey, MD; Steven Soignet, MD
Disclaimer: Both authors are paid consultants to Cell Therapeutics, Inc., the manufacturer of arsenic trioxide, and have participated in trials evaluating arsenic.
Learn more about subscription options.
Register Now for a free account.
Barbey JT, Soignet S. Prolongation of the QT Interval and Ventricular Tachycardia in Patients Treated with Arsenic Trioxide for Acute Promyelocytic Leukemia. Ann Intern Med. 2001;135:842. doi: 10.7326/0003-4819-135-9-200111060-00021
Download citation file:
Published: Ann Intern Med. 2001;135(9):842.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only